S.L.E. Lupus Foundation - Leading the Fight Against Lupus

February 2007
For more than 35 years, the S.L.E. Lupus Foundation has been providing help for people with lupus and their families, funding lupus research and fostering public awareness of this chronic illness.

What's New
 
February is American Heart Month

This month, the Foundation urges you to follow your heart — and learn more about the link between lupus and heart disease.

Heart disease is the nation’s number one killer of women. But many people are unaware that lupus dramatically raises this risk. Young women with lupus in particular have had discouraging headlines to read recently, with studies showing that despite their youth, the disease automatically makes them as much as 50 times more likely than other young women to have a heart attack or angina (chest pain). Cardiovascular disease and stroke threaten the lives of more than a third of women with lupus.

According to key research, women with lupus under age 40 are nearly five times more likely to have atherosclerosis (hardening of the arteries) than their healthy, same-age peers. And that’s regardless of conventional risk factors like smoking, high cholesterol, advanced age, high blood pressure, obesity, and diabetes.

To learn more about how lupus affects the heart, visit our website:

+ An Introduction to Lupus & The Heart »

+ More Advanced Information on Lupus & The Heart »

Learn More About Lupus
 
Your Doctor, Your Partner in Health

Get tips for improving your relationship with your doctor in the latest issue of
The Cooperative Corner
— the newsletter of the Lupus Cooperative of New York.

Lupus
Cooperative of New York
Lupus is a lifelong disease. It may get quiet and go into remission, but it doesn’t just go away for good. To deal with this uncertainty and all the health problems that can come up when you have lupus, it’s worth spending the time and effort to form as strong and positive a relationship as possible—a partnership—with the people who will be treating you along the way.
Read the article here »
En español »


Other recent topics in The Cooperative Corner:

+ New Lupus Support Group in Brooklyn!
Beginning this month, the Lupus Cooperative of New York (LCNY) will partner with New York Methodist Hospital to host a new bilingual support group where people with lupus can meet others with the disease and share strategies for coping. Attendees will also get to learn more about the LCNY's new Brooklyn Division. Friends and family of lupus patients are welcome.
First Meeting: Wednesday, February 15, 2007 at 7 p.m. Learn More »

+ Why Should You Care About Clinical Trials?
En español »

+ Looking Out for Lupus Flares
En español »

+ Bone Up on Lupus and Osteoporosis
En español »

Living with Lupus

Lupus at Work

Blakely, a young woman with lupus working in New York City, shares her thoughts on how to balance living with lupus and a professional career. Read her story here »

Want to read more stories of people with lupus? Visit the Living With Lupus section on our website. This feature explores emotional, psychosocial and lifestyle issues in lupus through the personal stories of New Yorkers with lupus.
More »

S.L.E. Lupus Foundation Spring Raffle
 

Buy Your Tickets Today and Help Us Get Closer to the Cure!

GRAND PRIZE - $10,000
Second Prize - $1,000*
*3 winners

Purchase Tickets Online Now »

Catch the Early Bird Special:
If you buy 4 tickets before Monday, April 30th, you'll get 1 free (5 for $100)!

Raffle Drawing: Friday, June 15, 2007

Note: Total prize money awarded will be reduced proportionately if fewer than 1,750 tickets are sold.
Research News
 
+ Attention New York Metro Area Lupus Researchers:
S.L.E. Lupus Foundation 2007 Research Grant Request for Applications Are Available »
Read more about the S.L.E. Lupus Foundation Research Program »


+ On December 18th the FDA warned of safety concerns regarding the treatment of lupus patients with Rituxan.
People with lupus who have questions or concerns should contact their doctor.
Press Release: FDA warns of safety concern regarding Rituxan in new patient population
FDA Public Health Advisory: Life-threatening brain infection in patients with systemic lupus erythematosus after Rituxan (Rituximab) treatment


+ Cautious Optimism on New Drugs for Lupus »
Special scientific conference session by S.L.E. Lupus Foundation partner, the Lupus Research Institute (LRI), features perspectives from biotech, pharma, and academia

More News »

Drug Development News »

Become a Member!
 

As a member of the S.L.E. Lupus Foundation, you will receive all the latest newsletters, research news and invitations to educational and fundraising events.



 

Contact Information

phone: 212.685.4118
Join our mailing list!